Conditional view: RKLB strangles look expensive in absolute terms, but not clearly “overpriced” versus their own recent volatility history. The important distinction is that the 30-day IV of 89.27% is high, yet its IV percentile is only 33.47% —so this is not near the top of its recent IV range.
Rocket Lab (RKLB)
watchlist
closed at US$54.43 on 2026-11-04 , up 4.53% .


Volatility premium: 30-day IV is 1.24× historical volatility , meaning implied volatility is pricing a 24% premium to the historical-volatility reference. That makes long premium less forgiving if the post-launch move fades and realized volatility normalizes.
But a major event remains: RKLB is scheduled to report 2026Q3 earnings after the close on 2026-11-09 . That is inside the 30-day window, so some elevated IV is rational; it is not simply residual launch excitement.
Options positioning is call-heavy: call/put volume ratio is 1.84 , while put/call is 0.54 . This can support upside-demand pricing, but it also raises